The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes
IgA nephropathy (IgAN) is a rather uncommon complication of TNF-alpha inhibition with a range of findings such as asymptomatic microscopic/macroscopic hematuria or different degrees of proteinuria and could progress to end-stage renal disease. We are reporting three patients with longstanding rheuma...
Saved in:
Main Authors: | Vedran Premužić, Ivan Padjen, Mislav Cerovec, Marijana Ćorić, Bojan Jelaković, Branimir Anić |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2020/9480860 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disseminated Mycobacterium Tuberculosis and IgA Nephropathy
by: Gordon Audley, et al.
Published: (2022-01-01) -
The road ahead: emerging therapies for primary IgA nephropathy
by: Edward J. Filippone, et al.
Published: (2025-02-01) -
Pathological Role of Tonsillar B Cells in IgA Nephropathy
by: Yusuke Suzuki, et al.
Published: (2011-01-01) -
Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
by: Claudio Pozzi, et al.
Published: (2012-01-01) -
External Validation of the International Prognosis Prediction Model of IgA Nephropathy
by: Lichao Hu, et al.
Published: (2024-12-01)